AIBOTICS, INC. Files Q1 2025 10-Q

Ticker: AIBT · Form: 10-Q · Filed: May 20, 2025 · CIK: 1763329

Aibotics, INC. 10-Q Filing Summary
FieldDetail
CompanyAibotics, INC. (AIBT)
Form Type10-Q
Filed DateMay 20, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, financials, company-information

TL;DR

AIBOTICS, INC. 10-Q filed for Q1 2025. Formerly Mycotopia Therapies.

AI Summary

AIBOTICS, INC. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Mycotopia Therapies, Inc. and 20/20 Global, Inc., is in the medicinal chemicals & botanical products sector. Its principal business address is in Heyburn, ID.

Why It Matters

This filing provides investors with the latest financial and operational updates for AIBOTICS, INC. for the first quarter of 2025.

Risk Assessment

Risk Level: low — This is a standard 10-Q filing with no immediate red flags or significant new information presented in the provided snippet.

Key Players & Entities

FAQ

What is the primary business of AIBOTICS, INC.?

AIBOTICS, INC. is in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector, SIC code 2833.

When is the reporting period for this 10-Q filing?

The conformed period of report is March 31, 2025.

What were AIBOTICS, INC.'s former names?

AIBOTICS, INC. was formerly known as Mycotopia Therapies, Inc. and 20/20 Global, Inc.

Where is AIBOTICS, INC. located?

The company's business and mailing address is 480 22ND STREET, HEYBURN, ID 83336.

What is the SEC file number for AIBOTICS, INC.?

The SEC file number for AIBOTICS, INC. is 000-56022.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 20, 2025 regarding AIBOTICS, INC. (AIBT).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing